414 related articles for article (PubMed ID: 21616186)
1. Regulation of cellular miRNA expression by human papillomaviruses.
Zheng ZM; Wang X
Biochim Biophys Acta; 2011; 1809(11-12):668-77. PubMed ID: 21616186
[TBL] [Abstract][Full Text] [Related]
2. Reversible repression of papillomavirus oncogene expression in cervical carcinoma cells: consequences for the phenotype and E6-p53 and E7-pRB interactions.
von Knebel Doeberitz M; Rittmüller C; Aengeneyndt F; Jansen-Dürr P; Spitkovsky D
J Virol; 1994 May; 68(5):2811-21. PubMed ID: 8151752
[TBL] [Abstract][Full Text] [Related]
3. Human Papillomavirus E6/E7 and Long Noncoding RNA TMPOP2 Mutually Upregulated Gene Expression in Cervical Cancer Cells.
He H; Liu X; Liu Y; Zhang M; Lai Y; Hao Y; Wang Q; Shi D; Wang N; Luo XG; Ma W; Zhang TC
J Virol; 2019 Apr; 93(8):. PubMed ID: 30728257
[TBL] [Abstract][Full Text] [Related]
4. Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35).
McFarlane M; MacDonald AI; Stevenson A; Graham SV
J Virol; 2015 May; 89(10):5276-87. PubMed ID: 25717103
[TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus type 16 E6 induces cervical cancer cell migration through the p53/microRNA-23b/urokinase-type plasminogen activator pathway.
Au Yeung CL; Tsang TY; Yau PL; Kwok TT
Oncogene; 2011 May; 30(21):2401-10. PubMed ID: 21242962
[TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus type 16 E6 suppresses microRNA-23b expression in human cervical cancer cells through DNA methylation of the host gene C9orf3.
Yeung CL; Tsang TY; Yau PL; Kwok TT
Oncotarget; 2017 Feb; 8(7):12158-12173. PubMed ID: 28077801
[TBL] [Abstract][Full Text] [Related]
7. Oncogenic HPV infection interrupts the expression of tumor-suppressive miR-34a through viral oncoprotein E6.
Wang X; Wang HK; McCoy JP; Banerjee NS; Rader JS; Broker TR; Meyers C; Chow LT; Zheng ZM
RNA; 2009 Apr; 15(4):637-47. PubMed ID: 19258450
[TBL] [Abstract][Full Text] [Related]
8. Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways.
Goodwin EC; DiMaio D
Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12513-8. PubMed ID: 11070078
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of p18Ink4c expression by oncogenic HPV E6 via p53-miR-34a pathway.
Wang X; Meyers C; Guo M; Zheng ZM
Int J Cancer; 2011 Sep; 129(6):1362-72. PubMed ID: 21128241
[TBL] [Abstract][Full Text] [Related]
10. Phylogenetic and functional analysis of sequence variation of human papillomavirus type 31 E6 and E7 oncoproteins.
Ferenczi A; Gyöngyösi E; Szalmás A; László B; Kónya J; Veress G
Infect Genet Evol; 2016 Sep; 43():94-100. PubMed ID: 27197052
[TBL] [Abstract][Full Text] [Related]
11. Reduction of microRNA-184 by E6 oncoprotein confers cisplatin resistance in lung cancer via increasing Bcl-2.
Tung MC; Lin PL; Cheng YW; Wu DW; Yeh SD; Chen CY; Lee H
Oncotarget; 2016 May; 7(22):32362-74. PubMed ID: 27083050
[TBL] [Abstract][Full Text] [Related]
12. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells.
Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB
Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252
[TBL] [Abstract][Full Text] [Related]
13. IFN-β antiproliferative effect and miRNA regulation in Human Papilloma Virus E6- and E7-transformed keratinocytes.
Chiantore MV; Mangino G; Iuliano M; Zangrillo MS; De Lillis I; Vaccari G; Accardi R; Tommasino M; Fiorucci G; Romeo G
Cytokine; 2017 Jan; 89():235-238. PubMed ID: 26748726
[TBL] [Abstract][Full Text] [Related]
14. MicroRNAs in cervical cancer: evidences for a miRNA profile deregulated by HPV and its impact on radio-resistance.
Pedroza-Torres A; López-Urrutia E; García-Castillo V; Jacobo-Herrera N; Herrera LA; Peralta-Zaragoza O; López-Camarillo C; De Leon DC; Fernández-Retana J; Cerna-Cortés JF; Pérez-Plasencia C
Molecules; 2014 May; 19(5):6263-81. PubMed ID: 24840898
[TBL] [Abstract][Full Text] [Related]
15. The high-risk HPV oncogene E7 upregulates miR-182 expression through the TGF-β/Smad pathway in cervical cancer.
Chen J; Deng Y; Ao L; Song Y; Xu Y; Wang CC; Choy KW; Tony Chung KH; Du Q; Sui Y; Yang T; Yang J; Li H; Zou C; Tang T
Cancer Lett; 2019 Sep; 460():75-85. PubMed ID: 31247272
[TBL] [Abstract][Full Text] [Related]
16. 5azadC treatment upregulates miR-375 level and represses HPV16 E6 expression.
Morel A; Baguet A; Perrard J; Demeret C; Jacquin E; Guenat D; Mougin C; Prétet JL
Oncotarget; 2017 Jul; 8(28):46163-46176. PubMed ID: 28521287
[TBL] [Abstract][Full Text] [Related]
17. microRNAs are biomarkers of oncogenic human papillomavirus infections.
Wang X; Wang HK; Li Y; Hafner M; Banerjee NS; Tang S; Briskin D; Meyers C; Chow LT; Xie X; Tuschl T; Zheng ZM
Proc Natl Acad Sci U S A; 2014 Mar; 111(11):4262-7. PubMed ID: 24591631
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus type 16 reduces the expression of microRNA-218 in cervical carcinoma cells.
Martinez I; Gardiner AS; Board KF; Monzon FA; Edwards RP; Khan SA
Oncogene; 2008 Apr; 27(18):2575-82. PubMed ID: 17998940
[TBL] [Abstract][Full Text] [Related]
19. Proinflammatory cytokine TNFα promotes HPV-associated oral carcinogenesis by increasing cancer stemness.
Hong HS; Akhavan J; Lee SH; Kim RH; Kang MK; Park NH; Shin KH
Int J Oral Sci; 2020 Jan; 12(1):3. PubMed ID: 31911577
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-18a targeting of the STK4/MST1 tumour suppressor is necessary for transformation in HPV positive cervical cancer.
Morgan EL; Patterson MR; Ryder EL; Lee SY; Wasson CW; Harper KL; Li Y; Griffin S; Blair GE; Whitehouse A; Macdonald A
PLoS Pathog; 2020 Jun; 16(6):e1008624. PubMed ID: 32555725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
